Cambridge Biomedical

Interested in working with

Cambridge Biomedical?

Overview

Since its establishment in 1997, Cambridge Biomedical has supported sponsors and CRO's developing customized assays for small and large molecules, biomarkers, diagnostics, and medical devices. Our team has expertise and extensive experience in technology transfer, assay development, optimization, and validation. We are positioned to work with you at preclinical, clinical, and post market stages of drug or device development.

Standards & Methodologies

Quantitative Immunoassays, Speciality & Custom Diagnostic Tests, Cell Based Assays, Colorimetry, Electrochemiluminescence/MSD , Electrophoresis, ELISA, Flow Cytometry, HPLC, IHC, Luminex®/QuantiGene®, PCR/qPCR/RT-PCR, Representative Instrument Capabilites, RIA, Western Blot

Qualifications, Certifications, Accreditations & Licenses

CAP CLIA FDA Registration State of California Department of Health Services State of Florida Agency for Healthcare Administration Maryland Department of Health and Mental Hygiene Commonwealth of Massachusetts Department of Public Health Commonwealth of Massachusetts Radiation Control Program New Jersey Office of the Attorney General New York State Department of Public Health Pennsylvania Department of Health Rhode Island Department of Health

Industries Served

  • Clinical Research

Testing Types

  • Biomedical
  • Clinical Diagnostic
  • Clinical Trials
  • Preclinical

Publications

Cambridge Biomedical has not posted any publications.

DISCLAIMER: This Laboratory Profile was provided by the company above.